Spronck, Bart;
Terentes-Printzios, Dimitrios;
Avolio, Alberto P;
Boutouyrie, Pierre;
Guala, Andrea;
Jerončić, Ana;
Laurent, Stéphane;
... Association for Research into Arterial Structure and Physiology; + view all
(2023)
2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.
Hypertension
10.1161/HYPERTENSIONAHA.123.21618.
(In press).
Preview |
PDF
spronck-et-al-2023-2024-recommendations-for-validation-of-noninvasive-arterial-pulse-wave-velocity-measurement-devices.pdf - Published Version Download (1MB) | Preview |
Abstract
BACKGROUND: Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new devices for assessing PWV, it has become evident that some of these devices yield results that display significant discrepancies compared with previous devices. This discrepancy underscores the importance of comprehensive validation procedures and the need for international recommendations. METHODS: A stepwise approach utilizing the modified Delphi technique, with the involvement of key scientific societies dedicated to arterial stiffness research worldwide, was adopted to formulate, through a multidisciplinary vision, a shared approach to the validation of noninvasive arterial PWV measurement devices. RESULTS: A set of recommendations has been developed, which aim to provide guidance to clinicians, researchers, and device manufacturers regarding the validation of new PWV measurement devices. The intention behind these recommendations is to ensure that the validation process can be conducted in a rigorous and consistent manner and to promote standardization and harmonization among PWV devices, thereby facilitating their widespread adoption in clinical practice. CONCLUSIONS: It is hoped that these recommendations will encourage both users and developers of PWV measurement devices to critically evaluate and validate their technologies, ultimately leading to improved consistency and comparability of results. This, in turn, will enhance the clinical utility of PWV as a valuable tool for assessing arterial stiffness and informing cardiovascular risk stratification and management in individuals with hypertension.
| Type: | Article |
|---|---|
| Title: | 2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1161/HYPERTENSIONAHA.123.21618 |
| Publisher version: | https://doi.org/10.1161/HYPERTENSIONAHA.123.21618 |
| Language: | English |
| Additional information: | © 2023 The Authors.Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
| Keywords: | aorta, cardiovascular diseases, guideline, pulse wave analysis, vascular stiffness |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Population Science and Experimental Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10182012 |
Archive Staff Only
 |
View Item |
